G protein-coupled receptors

G protein-coupled receptors
Name	G protein-coupled receptors
Caption	Schematic of a typical GPCR structure
Width	220

G protein-coupled receptors. They represent the largest and most diverse group of membrane receptors in eukaryotes, mediating cellular responses to an immense array of external signals. These receptors are integral to countless physiological processes, from sensory perception to hormone action, and are the target for a substantial proportion of modern pharmaceutical drugs. Their defining characteristic is a conserved structural architecture that enables them to transduce extracellular ligand binding into intracellular signaling via heterotrimeric G proteins.

Structure and classification

The canonical structure consists of a single polypeptide chain that threads back and forth across the cell membrane seven times, forming transmembrane domains connected by alternating intracellular loops and extracellular loops. This architecture creates a binding pocket for ligands, which can vary from small neurotransmitters like dopamine to large glycoprotein hormones. The International Union of Basic and Clinical Pharmacology maintains a systematic classification system, organizing these receptors into six main classes (A through F) based on sequence homology and functional characteristics. Class A, also known as the rhodopsin-like family, is by far the largest, encompassing receptors for biogenic amines, peptides, and olfactory receptors. Other classes include the secretin receptor family (Class B) and the metabotropic glutamate receptor family (Class C).

Signal transduction mechanism

Activation begins when a specific agonist binds to the receptor's orthosteric site, inducing a conformational change. This change facilitates the exchange of guanosine diphosphate for guanosine triphosphate on the Gα subunit of the associated heterotrimeric G protein. This exchange triggers the dissociation of the Gα subunit from the stable Gβγ complex, allowing both components to regulate downstream effector proteins. These effectors include enzymes like adenylyl cyclase, which produces the second messenger cyclic adenosine monophosphate, and phospholipase C, which generates inositol trisphosphate and diacylglycerol. The specific G protein subtype (e.g., G_s, G_i, G_q) determines the cellular response pathway.

Physiological roles and examples

These receptors are fundamental to virtually every organ system. In the nervous system, they mediate the actions of serotonin, norepinephrine, and GABA to regulate mood, arousal, and synaptic transmission. In the cardiovascular system, adrenergic receptors control heart rate and vasoconstriction. Sensory perception relies heavily on specialized receptors; rhodopsin in the retina detects light, while a vast array of olfactory receptors in the nasal epithelium enable the sense of smell. The hypothalamic-pituitary-adrenal axis utilizes receptors for corticotropin-releasing hormone and adrenocorticotropic hormone to coordinate the stress response.

Ligands and pharmacology

Ligands are chemically diverse and include endogenous compounds like hormones, neurotransmitters, and chemokines, as well as exogenous molecules such as pharmaceutical drugs, toxins, and odorants. Pharmacological agents are classified as agonists, which mimic natural ligands and activate the receptor, or antagonists, which block activation. Notable examples include the beta blocker propranolol, an antagonist at β-adrenergic receptors, and the antihistamine loratadine, which targets histamine H1 receptors. The discovery of allosteric modulators, which bind to distinct sites and modulate receptor activity, has expanded therapeutic strategies, exemplified by cinacalcet acting on the calcium-sensing receptor.

Regulation and desensitization

To prevent overstimulation, receptors undergo tightly regulated processes. Receptor desensitization often begins with phosphorylation of the receptor's intracellular loops and C-terminus by specific G protein-coupled receptor kinases. This phosphorylation promotes the binding of arrestin proteins, which sterically uncouple the receptor from its G protein. Arrestins also facilitate receptor internalization via clathrin-coated pits, leading to either lysosomal degradation or receptor recycling back to the plasma membrane. Longer-term regulation involves changes in gene expression, as seen in tachyphylaxis to repeated drug administration.

Research and therapeutic significance

Research in this field has been recognized by multiple Nobel Prize awards, including those to Robert Lefkowitz and Brian Kobilka for studies of receptor structure and function. Their work, utilizing techniques like X-ray crystallography and cryo-electron microscopy, has revealed detailed activation mechanisms. Given their central role in disease pathophysiology, they are targets for drugs treating conditions ranging from hypertension and asthma to schizophrenia and migraine. The concept of biased agonism, where ligands preferentially activate specific signaling pathways, represents a major frontier in developing safer, more effective therapeutics with fewer adverse effects.

Category:Cell signaling Category:Protein families Category:Membrane proteins